Foamix Pharmaceuticals Ltd. Proceeds from Issuance Initial Public Offering
Foamix Pharmaceuticals Ltd. reported Proceeds from Issuance Initial Public Offering of $41.09 million for the 12-month period ending 2014-12-31, per its 20-F filed 2015-03-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2015-03-17
| Period end | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|
| 2014-12-31 | $41.09M 20-F · filed 2015-03-17 |